Trademark: 97539827
Word
X
Status Date
Tuesday, April 30, 2024
Filing Date
Monday, August 8, 2022
Published for Opposition
Tuesday, September 19, 2023
40 Custom manufacture of oligonucleotides
5 Oligonucleotide compounds for use as pharmaceutical therapies for the treatment of a wide variety of conditions and illnesses; Oligonucleotide delivery agents that facilitate delivery of a wide range of pharmaceutical therapies; Oligonucleotide-based or -derived pharmaceuticals for the treatment of a wide variety of conditions and illnesses; Pharmaceuticals comprised of oligonucleotide compounds for the treatment of a wide variety of conditions and illnesses ; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents; Drug delivery agents consisting of oligonucleotide compounds that facilitate delivery of a wide range of pharmaceuticals
1 Oligonucleotide compounds for use in the manufacture of pharmaceutical therapies
42 Research and development of oligonucleotide compounds for use in pharmaceutical therapies; Research and development of oligonucleotide delivery agents for use in pharmaceutical therapies; Research and development of oligonucleotide-based or -derived pharmaceuticals; Research and development of pharmaceuticals comprised of oligonucleotide compounds; Research and development of oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents; Research and development of drug delivery agents consisting of oligonucleotide compounds
The mark consists of a series of short horizontal lines formed into the shape of an "X", superimposed on and largely within a diamond shape with rounded corners.
Color is not claimed as a feature of the mark.
Aug 11, 2022
New Application Entered
Aug 29, 2022
New Application Office Supplied Data Entered
Aug 30, 2022
Notice Of Design Search Code E-Mailed
May 24, 2023
Assigned To Examiner
Jun 16, 2023
Non-Final Action Written
Jun 16, 2023
Non-Final Action E-Mailed
Jun 16, 2023
Notification Of Non-Final Action E-Mailed
Aug 2, 2023
Teas Response To Office Action Received
Aug 12, 2023
Approved For Pub - Principal Register
Aug 2, 2023
Correspondence Received In Law Office
Aug 2, 2023
Teas/Email Correspondence Entered
Sep 19, 2023
Published For Opposition
Sep 19, 2023
Official Gazette Publication Confirmation E-Mailed
Nov 14, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 30, 2024
Sou Teas Extension Received
Apr 30, 2024
Sou Extension 1 Filed
Apr 30, 2024
Sou Extension 1 Granted
May 1, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 30, 2023
Notification Of Notice Of Publication E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
